- Home
- IRON vs BWLP Comparison
IRON vs BWLP Comparison
Compare IRON & BWLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- BWLP
- Stock Information
- Founded
- IRON 2017
- BWLP 1935
- Country
- IRON United States
- BWLP Singapore
- Employees
- IRON N/A
- BWLP N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- BWLP Marine Transportation
- Sector
- IRON Health Care
- BWLP Consumer Discretionary
- Exchange
- IRON Nasdaq
- BWLP Nasdaq
- Market Cap
- IRON 2.1B
- BWLP 2.4B
- IPO Year
- IRON N/A
- BWLP N/A
- Fundamental
- Price
- IRON $85.63
- BWLP $12.45
- Analyst Decision
- IRON Strong Buy
- BWLP
- Analyst Count
- IRON 13
- BWLP 0
- Target Price
- IRON $102.23
- BWLP N/A
- AVG Volume (30 Days)
- IRON 623.6K
- BWLP 422.4K
- Earning Date
- IRON 11-11-2025
- BWLP 11-27-2025
- Dividend Yield
- IRON N/A
- BWLP 10.80%
- EPS Growth
- IRON N/A
- BWLP N/A
- EPS
- IRON N/A
- BWLP 1.50
- Revenue
- IRON N/A
- BWLP $3,554,740,000.00
- Revenue This Year
- IRON N/A
- BWLP N/A
- Revenue Next Year
- IRON N/A
- BWLP $3.46
- P/E Ratio
- IRON N/A
- BWLP $8.82
- Revenue Growth
- IRON N/A
- BWLP 1.27
- 52 Week Low
- IRON $30.82
- BWLP $7.86
- 52 Week High
- IRON $95.95
- BWLP $16.60
- Technical
- Relative Strength Index (RSI)
- IRON 69.02
- BWLP 37.82
- Support Level
- IRON $83.52
- BWLP $11.87
- Resistance Level
- IRON $89.00
- BWLP $12.87
- Average True Range (ATR)
- IRON 3.84
- BWLP 0.36
- MACD
- IRON 1.08
- BWLP 0.02
- Stochastic Oscillator
- IRON 64.05
- BWLP 35.78
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
About BWLP BW LPG Limited Common Shares
BW LPG Ltd is an LPG shipping. It uses pioneering technology to power its vessels with cleaner-burning liquefied petroleum gas (LPG) and invest in R&D to take towards a zero-carbon future. The company is organized into two main segments: The shipping segment and the product services segment which buy and sell liquid petroleum gas and deliver it to customers. It generates the majority of its revenue from the shipping segment.